These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4294765)

  • 1. [Study in the unique cycle of wild and modified foot-and-mouth disease virus].
    Markovits P
    Acta Vet Acad Sci Hung; 1967; 17(3):287-92. PubMed ID: 4294765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of multiple infection on the reproduction of the virus of foot-and-mouth disease].
    Kravets IK; Ivanova IA
    Veterinariia; 1972 Sep; 9():56-8. PubMed ID: 4354913
    [No Abstract]   [Full Text] [Related]  

  • 3. [Foot and mouth disease virus].
    Palma EL
    Rev Asoc Argent Microbiol; 1975; 7(3):111-24. PubMed ID: 185664
    [No Abstract]   [Full Text] [Related]  

  • 4. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 5. Further information on the survival of modified foot-and-mouth disease virus in cattle.
    Augé de Mello P; Honigman MN; Fernandes MV; Gomes I
    Bull Off Int Epizoot; 1970; 73(5):489-505. PubMed ID: 4337797
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of replication of foot-and-mouth disease virus in infected cells].
    Shestochenko MA; Karev VP; Rostovtseva IA; Chernyshova GT
    Veterinariia; 1968 Jul; 45(7):22-3. PubMed ID: 4310522
    [No Abstract]   [Full Text] [Related]  

  • 7. Changed environmental conditions affecting normal body temperature of mice and its effect on the multiplication of foot and mouth disease virus.
    Gorhe DS; Asso J; Markovits P
    Indian Vet J; 1969 Apr; 46(4):278-84. PubMed ID: 4307099
    [No Abstract]   [Full Text] [Related]  

  • 8. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation and characterization of monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Amineva SP; Davydova NL; Mamatkulova LU; Globenko LA; Mishchenko VA
    Biochemistry (Mosc); 1997 May; 62(5):469-73. PubMed ID: 9275286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of foot-and-mouth disease viral antigens in mammary gland of infected cows.
    Blackwell JH; Yilma T
    Am J Vet Res; 1981 May; 42(5):770-3. PubMed ID: 6266292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tilting rack for cell cultures during replication of foot-and-mouth disease virus.
    Patty RE
    Am J Vet Res; 1972 Aug; 33(8):1715-7. PubMed ID: 4340057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Foot and mouth disease induced by a vaccinal strain of the virus].
    Bychkovskii VN
    Vrach Delo; 1972 Aug; 8():150-1. PubMed ID: 4342149
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune response to foot-and-mouth disease virus.
    Cowan KM; Wagner GG
    J Dairy Sci; 1971 Sep; 54(9):1329-30. PubMed ID: 4328704
    [No Abstract]   [Full Text] [Related]  

  • 15. Storage-related potency changes in monovalent type O1, A5 and C foot-and-mouth disease vaccine preparations.
    Sólyom F; Fazekas A; Czelleng F
    Acta Vet Acad Sci Hung; 1981; 28(3):289-95. PubMed ID: 6266237
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on live foot-and-mouth disease virus vaccines].
    Palacios CA
    Bol Oficina Sanit Panam; 1968 May; 64(5):386-410. PubMed ID: 4300940
    [No Abstract]   [Full Text] [Related]  

  • 17. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimicking foot-and-mouth disease virus antigens with synthetic peptides.
    Rowlands DJ
    Ann Sclavo Collana Monogr; 1984; 1(2):147-61. PubMed ID: 6100728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protein and ribonucleic acid biosynthesis in the cells in the replication of the foot-and-mouth disease virus].
    Khazipov NZ; Tiurikova RP
    Veterinariia; 1973 May; 49(5):65-7. PubMed ID: 4353690
    [No Abstract]   [Full Text] [Related]  

  • 20. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.